Anne J Novak

EmailNovak.Annemayoedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Anne J Novak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Finished

Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
Novak, A. J. & Cerhan, J. R.
National Cancer Institute
8/1/17 → 7/31/18
Project: Research project

109 Article
8 Letter
3 Review article
2 Comment/debate
More
- 1 Chapter

Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma
Anagnostou, T., Yang, Z. Z., Jalali, S., Kim, H. J., Larson, D. P., Tang, X., Yu, Y., Pritchett, J. C., Bisneto, J. V., Price-Troska, T. L., Mondello, P., Novak, A. J. & Ansell, S. M., 2023, (Accepted/In press) In: Leukemia.
Research output: Contribution to journal › Article › peer-review
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Mondello, P., Paludo, J., Novak, J. P., Wenzl, K., Yang, Z. Z., Jalali, S., Krull, J. E., Braggio, E., Dasari, S., Manske, M. K., Abeykoon, J. A., Sarangi, V., Kapoor, P., Paulus, A., Reeder, C. B., Ailawadhi, S., Chanan-Khan, A. A., Kyle, R. A., Gertz, M. A., Novak, A. J., & 1 othersAnsell, S. M., Mar 1 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 5, p. 957-970 14 p.
Research output: Contribution to journal › Article › peer-review
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
Tun, A. M., Khurana, A., Mwangi, R., Link, B. K., Wang, Y., Feldman, A. L., Thompson, C. A., Novak, A. J., Villasboas, J. C., Thanarajasingam, G., Farooq, U., Syrbu, S., Nowakowski, G. S., Witzig, T. E., Ansell, S. M., Rimsza, L. M., Cerhan, J. R., Habermann, T. M. & Maurer, M. J., Sep 13 2022, In: Blood Advances. 6, 17, p. 5210-5221 12 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Berndt, S. I., Vijai, J., Benavente, Y., Camp, N. J., Nieters, A., Wang, Z., Smedby, K. E., Kleinstern, G., Hjalgrim, H., Besson, C., Skibola, C. F., Morton, L. M., Brooks-Wilson, A. R., Teras, L. R., Breeze, C., Arias, J., Adami, H. O., Albanes, D., Anderson, K. C., Ansell, S. M., & 119 othersBassig, B., Becker, N., Bhatti, P., Birmann, B. M., Boffetta, P., Bracci, P. M., Brennan, P., Brown, E. E., Burdett, L., Cannon-Albright, L. A., Chang, E. T., Chiu, B. C. H., Chung, C. C., Clavel, J., Cocco, P., Colditz, G., Conde, L., Conti, D. V., Cox, D. G., Curtin, K., Casabonne, D., De Vivo, I., Diver, W. R., Dogan, A., Edlund, C. K., Foretova, L., Fraumeni, J. F., Gabbas, A., Ghesquières, H., Giles, G. G., Glaser, S., Glenn, M., Glimelius, B., Gu, J., Habermann, T. M., Haiman, C. A., Haioun, C., Hofmann, J. N., Holford, T. R., Holly, E. A., Hutchinson, A., Izhar, A., Jackson, R. D., Jarrett, R. F., Kaaks, R., Kane, E., Kolonel, L. N., Kong, Y., Kraft, P., Kricker, A., Lake, A., Lan, Q., Lawrence, C., Li, D., Liebow, M., Link, B. K., Magnani, C., Maynadie, M., McKay, J., Melbye, M., Miligi, L., Milne, R. L., Molina, T. J., Monnereau, A., Montalvan, R., North, K. E., Novak, A. J., Onel, K., Purdue, M. P., Rand, K. A., Riboli, E., Riby, J., Roman, E., Salles, G., Sborov, D. W., Severson, R. K., Shanafelt, T. D., Smith, M. T., Smith, A., Song, K. W., Song, L., Southey, M. C., Spinelli, J. J., Staines, A., Stephens, D., Sutherland, H. J., Tkachuk, K., Thompson, C. A., Tilly, H., Tinker, L. F., Travis, R. C., Turner, J., Vachon, C. M., Vajdic, C. M., Van Den Berg, A., Van Den Berg, D. J., Vermeulen, R. C. H., Vineis, P., Wang, S. S., Weiderpass, E., Weiner, G. J., Weinstein, S., Doo, N. W., Ye, Y., Yeager, M., Yu, K., Zeleniuch-Jacquotte, A., Zhang, Y., Zheng, T., Ziv, E., Sampson, J., Chatterjee, N., Offit, K., Cozen, W., Wu, X., Cerhan, J. R., Chanock, S. J., Slager, S. L. & Rothman, N., Dec 2022, In: Leukemia. 36, 12, p. 2835-2844 10 p.
Research output: Contribution to journal › Article › peer-review
Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma
Tang, X., Yang, Z. Z., Kim, H. J., Anagnostou, T., Yu, Y., Wu, X., Chen, J., Krull, J. E., Wenzl, K., Mondello, P., Bhardwaj, V., Wang, J., Novak, A. J. & Ansell, S. M., Oct 1 2022, In: Clinical Cancer Research. 28, 19, p. 4322-4335 14 p.
Research output: Contribution to journal › Article › peer-review

Anne J Novak, PhD

Fingerprint

Network

Dive into details

Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma

Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma

Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma

Anne J Novak, PhD

Fingerprint

Network

Projects

Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma

Research output

Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma

Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma